Allaben W T, Weeks C E, Weis C C, Burger G T, King C M
Carcinogenesis. 1982;3(3):233-40. doi: 10.1093/carcin/3.3.233.
A single local injection of 2.5 mumol of N-hydroxy-N-formyl-2-aminofluorene (N-hydroxy-FAF), N-hydroxy-N-acetyl-2-aminofluorene (N-hydroxy-AAF), or N-hydroxy-N-pro-pionyl-2-aminofluorene )N-hydroxy-PAF) to each of the six left mammary glands of female Sprague-Dawley derived CD rats gave a mammary tumor incidence, after 12 months, of 53% for the N-acetyl (42% adenocarcinoma, 11% fibroadenoma), 41% for the N-formyl (8% adenocarcinoma, 11% sarcoma, 22% fibroadenoma), and 33% for the N-propionyl (11% adenocarcinoma, 22% fibroadenoma) derivatives of N-hydroxy-N-2-aminofluorene, Latent periods for malignant tumor appearance (adenocarcinoma or sarcoma) was 210 days, 148 days, and 177 days, respectively, with no malignant tumors occurring in the vehicle-treated animals. In contrast, latent periods for benign tumor appearance (fibroadenoma) was 263 days for control animals, 289 days for the N-hydroxy-AAF, 324 days for the N-hydroxy-FAF, and 317 days for the N-hydroxy-PAF animals. When N-acetyl-2-aminofluorene (AAF) was applied as above there was only an 8% mammary tumor incidence (4% adenocarcinoma, 4% fibroadenoma) with a latent period of 207 days for malignant tumor (adenocarcinoma) and 221 days for benign tumor (fibroadenoma) appearance. Arylhydroxamic acid N, O-acyltransferase activity has been demonstrated in the mammary glands of male, and lactating and non-lactating female Sprague-Dawley derived CD rats by means of nucleic acid binding assay. Mammary gland cytosol catalyzed tRNA adduct formation to a greater extent with N-hydroxy-FAF. AAF was not activated by this enzyme. Ammonium sulfate fractionation demonstrated the presence of two enzymes, one specific for N-hydroxy-FAF (70-80% fraction), the other specific for N-hydroxy-AAF and N-hydroxy-PAF (40-70% fraction). Moreover, gel filtration chromatography of mammary gland cytosol demonstrated the presence of two enzymes of differing acyl specificity. Mammary gland microsomes catalyzed the formation of tRNA adducts, but only with the N-hydroxy-FAF derivative. Assays that tested the mutagenic potential of the arylhydroxamic acids in Salmonella typhimurium TA-1538 with either mammary gland cytosol or microsomes demonstrated the order of mutagenicity to be N-hydroxy-FAF greater than N-hydroxy-AAF greater than N-hydroxy-PAF. A similar order of mutagenicity was demonstrated without an external metabolic activation system. These data demonstrate that the presence of two distinct enzymes in the rat mammary gland that activate arylhydroxamic acids.
向雌性斯普拉格 - 道利衍生的CD大鼠的六个左乳腺中,每个乳腺单次局部注射2.5微摩尔的N - 羟基 - N - 甲酰基 - 2 - 氨基芴(N - 羟基 - FAF)、N - 羟基 - N - 乙酰基 - 2 - 氨基芴(N - 羟基 - AAF)或N - 羟基 - N - 丙酰基 - 2 - 氨基芴(N - 羟基 - PAF),12个月后,N - 乙酰基衍生物的乳腺肿瘤发生率为53%(42%为腺癌,11%为纤维腺瘤),N - 甲酰基衍生物为41%(8%为腺癌,11%为肉瘤,22%为纤维腺瘤),N - 丙酰基衍生物为33%(11%为腺癌,22%为纤维腺瘤),这些都是N - 羟基 - N - 2 - 氨基芴的衍生物。恶性肿瘤(腺癌或肉瘤)出现的潜伏期分别为210天、148天和177天,在接受赋形剂处理的动物中未出现恶性肿瘤。相比之下,良性肿瘤(纤维腺瘤)出现的潜伏期,对照动物为263天,N - 羟基 - AAF处理的动物为289天,N - 羟基 - FAF处理的动物为3